MedPath

Alarm Treatment for Combined Enuresis and Daytime Urinary Incontinence in Children

Not Applicable
Completed
Conditions
Incontinence, Urinary
Enuresis, Nocturnal
Enuresis
Interventions
Device: Enuresis Alarm Rodger and Timer watch (Rodger)
Device: Timer watch (Rodger)
Registration Number
NCT04260646
Lead Sponsor
Aalborg University Hospital
Brief Summary

The aim is to examine whether alarm therapy in addition to urotherapy can have a beneficial effect in treating urinary incontinence children with combined daytime incontinence and enuresis. The study will include children who suffers for combined daytime incontinence and enuresis and referred to one of the pediatric departments were offed to participate. Participants are randomized to 8 weeks treatment with either enuresis alarm and timer watch assist urotherapy or solely timer watch assisted urotherapy.

Detailed Description

Urinary incontinence are common disorders of school age children. Approximately 3.8 - 16.9 % of first grade children suffer from daytime incontinence (DUI) depending on the definitions. Half of the children with DUI suffers for enuresis (NE) too. The background for combined DUI and enuresis is in most children functional overactive bladder (OAB).

At present DUI is treated first with urotherapi, if insufficient bladder modulating drugs are added. When daytime continence is achieved, the enuresis is handled using (in cases of small bladder capacity) an enuresis alarm.

Whether daytime continence is a prerequisite for treating NE or whether enuresis alarm may positively influence DUI treatment has not been studies in a RCT previously.

The aim of this study is to examine whether alarm therapy in addition to urotherapy can have a beneficial effect in treating children with combined daytime incontinence and enuresis. Thus the hypothesis are:

1. That the enuresis alarm therapy is beneficial in DUI treatment.

2. That it is possible to treat enuresis before daytime continence has been achieved

Methods: The study is a randomized controlled trial. The participants will be approx. 90 children that suffers from combined enuresis and daytime urinary incontinence. The participants will be equally randomized to 8 week of timer watch assisted urotherapy 1) with or 2) without addition of enuresis alarm treatment. The study includes 3 outpatient visits and 2 phone contacts.

The participants will complete bladder diaries as well as drypie and nocturnal urine production registrations. Also registrations on number and time of enuresis will be recorded for the alarm group children. All children will be provided a timer watch.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
89
Inclusion Criteria
  • Age 5-14 years
  • Completed "Tørfisk" (Danish version of the Bower "Dry pie" Incontinence diary 1) and bladder diary (containing frequency and volume of voiding, fluid intake through 48 hours as well as 7 days night registering of nocturnal urine production (NUP) and wet nights.)
  • A minimum of 2 wet days per week
  • A minimum of 2 wet nights per week.
  • Average NUP (aNUP) on wet nights of less than 130 % of expected bladder capacity (EBC=30*(age+1))
  • Obtained oral and written informed consent from the participant and both custody holders.
Exclusion Criteria
  • Known renal- or urinary tracts anomalies that affects the incontinence
  • Ongoing urinary tracts infection (UTI)
  • Ongoing obstipation defined by ROM IV criteria
  • Glycosuria or proteinuria
  • Previously received treatment with anticholinergics
  • Previously received treatment with enuresis alarm
  • Sign on neurological or structural cause of the incontinence
  • Reduced compliance for alarm treatment defined as use of the alarm less than 80 % of the nights of the treatment period.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standard Urotherapy with enuresis alarmEnuresis Alarm Rodger and Timer watch (Rodger)Standard urotherapy inclunding normalized fluid intake and times voidings. The timed voiding regime of every 2 hours will be assisted by a timer Watch. In addition an enuresis alarm will be provided and worn by the participants during the night.
Standard Urotherapy without enuresis alarmTimer watch (Rodger)Standard urotherapy inclunding normalized fluid intake and times voidings. The timed voiding regime of every 2 hours will be assisted by a timer Watch.
Standard Urotherapy with enuresis alarmTimer watch (Rodger)Standard urotherapy inclunding normalized fluid intake and times voidings. The timed voiding regime of every 2 hours will be assisted by a timer Watch. In addition an enuresis alarm will be provided and worn by the participants during the night.
Primary Outcome Measures
NameTimeMethod
Change in Daytime incontinence-scoreScore will be calculated pre intervention, at week 2, 4, 6, and 8 of intervention

Incontinence-score calculated from Drypie scale between 0-21

Change in Relative number of wet nightsWill be calculated from registrations at baseline and week 8 of intervention

Number of wet nights pr week

Secondary Outcome Measures
NameTimeMethod
Change in Daytime urinary incontinence episodes (DUI episodes)Will be calculated from 48h registrations at baseline and at week 8 of intervention

Daytime urinary incontinence episodes by bladder diary (episodes per day)

Change in MVV (maximal voided volume)Will be calculated from 48h registrations at baseline and at week 8 of intervention

maximal voided volume from bladder diary in ml

Trial Locations

Locations (4)

Dept pediatrics, Aalborg University Hospital

🇩🇰

Aalborg, Denmark

dept Pediatrics, Aarhus University Hospital

🇩🇰

Aarhus N, Denmark

Børneafdelingen, Herning

🇩🇰

Herning, Denmark

Dept pediatrics, North Denmark Regional Hospital Hjoerring Hjoerring

🇩🇰

Hjørring, Denmark

© Copyright 2025. All Rights Reserved by MedPath